A Phase I, Open-Label, Single Sequence, Crossover Study Evaluating the Safety and the Pharmacokinetics of Lopinavir/Ritonavir and Eltrombopag Given Alone and When Co-Administered in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 16 Nov 2017
At a glance
- Drugs Eltrombopag (Primary) ; Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 30 Aug 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 06 Feb 2009 New trial record